BioTuesdays

Tag - NASDAQ

Liminal BioSciences

Liminal BioSciences to begin trading on NASDAQ

Common shares of Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) were approved for trading on the Nasdaq Global Market, effective Nov. 18, under the ticker symbol, LMNL. The shares will continue to trade on the Toronto...

Canaccord cuts Vermillion to hold; PT to $1

Canaccord Genuity downgraded Vermillion (NASDAQ:VRML) to “hold” from “buy” and lowered its price target to $1 from $2.25 after the company’s first quarter results missed estimates across the board. The stock closed at...

Ovid Therapeutics

Ladenburg starts Ovid Therapeutics at buy; PT $27

Ladenburg Thalmann initiated coverage of Ovid Therapeutics (NASDAQ:OVID) with a “buy” rating and $27 price target. The stock closed at $10.14 on April 19. Ovid is developing two clinical-stage candidates: OV101, a GABA...

Subscribe

Sign up to our weekly BioTuesdays newsletter.